Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/20/2017 03/21/2017 03/22/2017 03/23/2017 03/24/2017 Date
24.39(c) 24.14(c) 24.27(c) 24.25(c) 24.32(c) Last
3 707 487 4 881 757 4 850 918 4 410 127 3 813 302 Volume
-0.16% -1.03% +0.54% -0.08% +0.29% Change
More quotes
Financials ($)
Sales 2017 8 774 M
EBIT 2017 2 058 M
Net income 2017 1 339 M
Debt 2017 2 954 M
Yield 2017 -
Sales 2018 9 363 M
EBIT 2018 2 314 M
Net income 2018 1 701 M
Debt 2018 1 353 M
Yield 2018 -
P/E ratio 2017 26,00
P/E ratio 2018 20,50
EV / Sales2017 4,12x
EV / Sales2018 3,69x
Capitalization 33 160 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in a broad range of interventional medical specialties.Its products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive,... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
03/23 GLOBAL ARTIFICIAL URINARY SPHINCTER : Boston Scientific Corporation, ZEPHYR Sur..
03/17 BOSTON SCIENTIFIC : NICE Recommends Boston Scientific CRT-D Devices Powered By E..
03/17 BOSTON SCIENTIFIC : NICE Recommends Boston Scientific CRT-D Devices Powered By E..
03/16 BOSTON SCIENTIFIC : Receives Favorable Rulings In Edwards Lifesciences Litigatio..
03/16 BOSTON SCIENTIFIC : To Participate In Barclays Global Healthcare Conference
03/15 BOSTON SCIENTIFIC : Global Defibrillator Market 2017 – Defibtech, Boston S..
03/10 GERMAN COURT RULES IN FAVOR OF BOSTO : BSX) In Patent Case Against Edwards Lifes..
03/10 BOSTON SCIENTIFIC CORPORATION : Blog Coverage German and UK Courts Rule in Favor..
03/09 BOSTON SCIENTIFIC : Patent Issued for Polymers Containing Siloxane Monomers (USP..
03/09 BOSTON SCIENTIFIC : Announces Six Finalists in 2nd Annual Connected Patient Chal..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
2012All technical elements to short
More Strategies
Latest Tweets
12:01pNeovasc Inc (US)'s outperform rating reiterated at Leerink Swann.  
03/24 ? Here?s Our Take On The Recent Neovasc Inc (US) (NASDAQ:NVCN) Call via ?
1
03/24Neovasc Announces Results For The Fourth Quarter And Fiscal Year 2016  
03/23$NVCN rocking on recording a December $BSX one time gain in the numbers. Ma.. 
03/23Neovasc beats on revenue  
More tweets
Qtime:125
News from SeekingAlpha
03/16 Trump's proposed 2018 budget trims NIH funding 20%; healthcare stocks in the ..
03/09 Boston Scientific wins heart valve patent suit in Germany against Edwards
03/03 Edwards Lifesciences gets split decision in UK heart valve patent fight with ..
02/27 ELECTROPHYSIOLOGY DEVICES : Key Players In A Fast-Growing Market
02/27 No Lotus élan For Boston
Advertisement
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 28,1 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian Meredith Global Chief Medical Officer
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..12.44%33 160
THERMO FISHER SCIENTIF..9.17%60 136
DANAHER CORPORATION10.50%59 629
PHILIPS1.72%29 605
INTUITIVE SURGICAL, IN..19.53%27 838
ILLUMINA, INC.33.22%24 956
More Results